These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 30759742)
1. Lymphoproliferation Impairment and Oxidative Stress in Blood Cells from Early Parkinson's Disease Patients. Vida C; Kobayashi H; Garrido A; Martínez de Toda I; Carro E; Molina JA; De la Fuente M Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759742 [TBL] [Abstract][Full Text] [Related]
2. Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer's Disease Patients. Relevant Role of Neutrophils in Oxidative Stress. Vida C; Martinez de Toda I; Garrido A; Carro E; Molina JA; De la Fuente M Front Immunol; 2017; 8():1974. PubMed ID: 29375582 [TBL] [Abstract][Full Text] [Related]
3. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease. Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485 [TBL] [Abstract][Full Text] [Related]
4. [Study on changes of plasma levels of oxidative stress biomarkers and its relation with cognition function in patients with parkinson's disease]. Zhou H; Yuan Y; Qi Z; Tong Q; Zhang K Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(41):3357-60. PubMed ID: 26812976 [TBL] [Abstract][Full Text] [Related]
5. A multi-biomarker analysis of the antioxidant efficacy of Parkinson's disease therapy. Colamartino M; Duranti G; Ceci R; Sabatini S; Testa A; Cozzi R Toxicol In Vitro; 2018 Mar; 47():1-7. PubMed ID: 29080800 [TBL] [Abstract][Full Text] [Related]
6. Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations. Vinish M; Anand A; Prabhakar S Acta Biochim Pol; 2011; 58(2):165-9. PubMed ID: 21584286 [TBL] [Abstract][Full Text] [Related]
7. Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population. Sharma A; Kaur P; Kumar B; Prabhakar S; Gill KD Parkinsonism Relat Disord; 2008; 14(1):52-7. PubMed ID: 18032086 [TBL] [Abstract][Full Text] [Related]
8. Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways. de Farias CC; Maes M; Bonifacio KL; Matsumoto AK; Bortolasci CC; Nogueira AS; Brinholi FF; Morimoto HK; de Melo LB; Moreira EG; Barbosa DS CNS Neurol Disord Drug Targets; 2017; 16(4):484-491. PubMed ID: 28240188 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress indicators are elevated in de novo Parkinson's disease patients. Ilic TV; Jovanovic M; Jovicic A; Tomovic M Funct Neurol; 1999; 14(3):141-7. PubMed ID: 10568214 [TBL] [Abstract][Full Text] [Related]
10. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease]. Li J; Wang LN; Xiao HL; Li X; Yang JJ Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193 [TBL] [Abstract][Full Text] [Related]
11. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Chen CM; Liu JL; Wu YR; Chen YC; Cheng HS; Cheng ML; Chiu DT Neurobiol Dis; 2009 Mar; 33(3):429-35. PubMed ID: 19110057 [TBL] [Abstract][Full Text] [Related]
12. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers. Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood markers of oxidative stress in Parkinson's disease. Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220 [TBL] [Abstract][Full Text] [Related]
14. The glutathione system in Parkinson's disease and its progression. Bjørklund G; Peana M; Maes M; Dadar M; Severin B Neurosci Biobehav Rev; 2021 Jan; 120():470-478. PubMed ID: 33068556 [TBL] [Abstract][Full Text] [Related]
15. Interaction of systemic oxidative stress and mesial temporal network degeneration in Parkinson's disease with and without cognitive impairment. Chiang PL; Chen HL; Lu CH; Chen YS; Chou KH; Hsu TW; Chen MH; Tsai NW; Li SH; Lin WC J Neuroinflammation; 2018 Sep; 15(1):281. PubMed ID: 30257698 [TBL] [Abstract][Full Text] [Related]
16. Chromosome and oxidative damage biomarkers in lymphocytes of Parkinson's disease patients. Migliore L; Scarpato R; Coppede F; Petrozzi L; Bonuccelli U; Rodilla V Int J Hyg Environ Health; 2001 Oct; 204(1):61-6. PubMed ID: 11725348 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and Parkinson's disease. Ilić T; Jovanović M; Jovicić A; Tomović M Vojnosanit Pregl; 1998; 55(5):463-8. PubMed ID: 9921070 [TBL] [Abstract][Full Text] [Related]
18. Function and redox state of peritoneal leukocytes as preclinical and prodromic markers in a longitudinal study of triple-transgenic mice for Alzheimer's disease. Maté I; Cruces J; Giménez-Llort L; De la Fuente M J Alzheimers Dis; 2015; 43(1):213-26. PubMed ID: 25079793 [TBL] [Abstract][Full Text] [Related]